SMO ClinPlus Co. Ltd. Total Liabilities

Latest as of March 2026: CN¥243.37 Million CNY ≈ $35.61 Million USD

SMO ClinPlus Co. Ltd. total liabilities. Based on the latest financial reports, SMO ClinPlus Co. Ltd. (301257) has total liabilities worth CN¥243.37 Million CNY (≈ $35.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301257 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of SMO ClinPlus Co. Ltd. (2019–2025)

Total liabilities of SMO ClinPlus Co. Ltd. from 2019 to 2025. This chart illustrates how SMO ClinPlus Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data.

SMO ClinPlus Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of SMO ClinPlus Co. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Shape Australia Corporation Ltd
AU:SHA
Australia AU$303.84 Million
Zuming Bean Products Co Ltd
SHE:003030
China CN¥1.36 Billion
Schweiter Technologies AG
LSE:0QR1
UK £328.10 Million
Sinopec Oilfield Service Corporation
F:YIZH
Germany €66.96 Billion
Steelcast Limited
NSE:STEELCAS
India Rs-3.95 Billion
Shandong Longji Machinery Co Ltd
SHE:002363
China CN¥790.25 Million
Yulon Nissan Motor Co Ltd
TW:2227
Taiwan NT$4.69 Billion
Zhong Fu Tong Co Ltd
SHE:300560
China CN¥1.64 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down SMO ClinPlus Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SMO ClinPlus Co. Ltd. (301257) total assets.

Liquidity & Leverage Metrics

SMO ClinPlus Co. Ltd. Total Liabilities Ratios Explained

SMO ClinPlus Co. Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.99 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.16 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SMO ClinPlus Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SMO ClinPlus Co. Ltd. (2019–2025)

The table below shows the annual total liabilities of SMO ClinPlus Co. Ltd. from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥274.41 Million
≈ $40.16 Million
+6.99%
2024-12-31 CN¥256.48 Million
≈ $37.53 Million
-10.39%
2023-12-31 CN¥286.22 Million
≈ $41.88 Million
+37.11%
2022-12-31 CN¥208.75 Million
≈ $30.55 Million
+19.01%
2021-12-31 CN¥175.41 Million
≈ $25.67 Million
+37.65%
2020-12-31 CN¥127.43 Million
≈ $18.65 Million
+66.06%
2019-12-31 CN¥76.74 Million
≈ $11.23 Million
--

About SMO ClinPlus Co. Ltd.

SHE:301257 China Diagnostics & Research
Market Cap
$395.27 Million
CN¥2.70 Billion CNY
Market Cap Rank
#13093 Global
#3864 in China
Share Price
CN¥34.19
Change (1 day)
-3.85%
52-Week Range
CN¥31.50 - CN¥82.86
All Time High
CN¥82.86
About

SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project man… Read more